Back to library
SARMResearch

S-23

ess-two-three

Research profile · How we handle evidence

Category

SARM

Compound type

Phase / Status

Research

Investigational compound; not FDA approved for performance use. Human safety data are limited.

Standard Dose

10-25mg

Once daily

Half-life

2-3 days

Plasma elimination

Route(s)

IN / SU / OR

Intramuscular, Subcutaneous or Oral

Research Stage

Status Unknown

Research phase not specified; exercise appropriate caution.

Overview

S-23 is a SARM-like research compound studied for muscle-related signals. It may strongly influence the hypothalamic-pituitary-gonadal axis, which can lead to suppressed natural testosterone and other side effects. Clinical safety and efficacy for performance use are not established.

Plain-language summary

S-23 is a SARM-like research compound studied for muscle-related signals. It may strongly influence the hypothalamic-pituitary-gonadal axis, which can lead to suppressed natural testosterone and other side effects. Clinical safety and efficacy for performance use are not established.

Administration Routes

  • Intramuscular
  • Subcutaneous
  • Oral

Also known as

S23S 23GTx-023 analogThe SuppressorHard SARM

Mechanisms

1

Selective Androgen Receptor Modulator (SARM): binds to androgen receptors in target tissues. The overall physiological impact depends on dose, tissue selectivity, and individual biology.

Detailed mechanism

Selective Androgen Receptor Modulator (SARM) that binds to androgen receptors in tissues including muscle and prostate. The degree of suppression of endogenous hormones is a key safety consideration.

Safety

Side effects

  • Possible suppression of natural testosterone
  • Hair loss in those genetically predisposed
  • Potential lipid or liver enzyme changes
  • Possible libido changes and longer recovery for some

Reported benefits

  • Potential androgen-receptor signaling changes in research contexts
  • Oral administration

Safety profile

Limited human safety data. Potential risks include hormone suppression and organ effects; medical supervision is recommended for any clinical context.

Clinical trials

Research studies; not broadly established as an approved medication for performance purposes.

Structure

Verified structure

S-23

No public sequence, formula, or exact registry structure is available for this record.

Structure unavailable

No trustworthy illustration yet

This entry is missing a public exact structure, sequence, or usable formula. The verification record is still stored so it remains visible in the audit trail.

Chemical Formula
Not publicly available
Molecular Weight
Not publicly available
CAS Number
Not publicly available

Stack Context

Stacks with

CardarineNolvadex

References

  1. 1

    Selective androgen receptor modulators as male contraceptives (Contraception)

    2004

    View source
  2. 2

    Pharmacology of anabolic steroids (British Journal of Pharmacology)

    2008

    View source
  3. 3

    Selective androgen receptor modulators as function promoting therapies (Current Opinion in Clinical Nutrition and Metabolic Care)

    2009

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.